Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib Maintenance for FLT3-Negative Acute Leukemia Post-Transplant
NCT04674345Phase 3Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Dec 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sorafenib in acute leukemia, sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
sorafenib
03
Conditions
acute leukemia
Beyond the preview
Go deeper on NCT04674345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04674345.